Strategies for Improving Adherence Jerry Meece, R.Ph., F.A.C.A., C.D.E., Janice Pringle, Ph.D., Linda Siminerio, R.N., Ph.D., C.D.E. and John Miall, M.B.A. Identify barriers to diabetes self-management. Utilize motivational interviewing techniques to address barriers to adherence and improve diabetes self-management. Implement systems that maximize use of auxiliary staff to improve quality and efficiency of diabetes care. Discuss the importance of the pharmacist in improving medical management and adherence. Increase access to comprehensive diabetes care by partnering with pharmacists, certified diabetes educators, and other healthcare professionals. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Diabetes Prevention in a Post-DPP World Ann Albright, Ph.D., Jonathan Lever, Athena Philis–Tsimikas, M.D. and Judith Regensteiner, Ph.D. Counsel patients about the benefits of physical activity. Develop exercise plans based on current guidelines and patients’ baseline levels of fitness and motivation. Educate patients about community programs for diabetes prevention. Incorporate peer educators into the diabetes management team. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
New Developments in Beta Cell Research Christopher Rhodes, Ph.D., Michael Nauck, M.D., Ph.D., David D'Alessio, M.D., Stefano del Prato, M.D., Martha Pavlakis, M.D., Peter Senior, M.D. and George King, M.D. Educate patients about the function and importance of beta cell function in the progression of diabetes. Identify patients who may, or may not, benefit from simultaneous kidney and pancreas transplantation and refer accordingly. Counsel patients with type 2 diabetes on the potential use of islet cell transplantation. Educate patients about the Medalist study and the potential for diabetes patients to have lifespans equivalent to people without diabetes. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Under-Appreciated Risk Factors for Type 2 Diabetes Teresa Reyes, Ph.D., Steven Engebretson, D.M.D., M.S., Arun Sanyal, M.D., Frans Pouwer, Ph.D., Nancy Adler, Ph.D. and George Chrousos, M.D. Counsel women about the potential effects of diet during pregnancy and lactation on the future health of their children. Identify patients with a history of, or risk for, periodontal disease and refer accordingly. Screen patients with type 2 diabetes for hepatitis C viral infection. Incorporate screening questions for chronic stress and depression into wellness visits. Educate patients about suboptimal sleep as a risk factor for obesity and diabetes. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Medical Management: Evidence and Algorithms Robert Zimmerman, M.D., Mayer B. Davidson, M.D., Holly Divine, Pharm.D. and Richard Pratley, M.D. Individualize medical management and appropriately intensify therapy. Compare the safety profiles of the various classes of antidiabetes agents. Summarize the evidence comparing efficacy of different classes of antidiabetes agents. Engage patients in discussions about goals of therapy and potential barriers.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Therapeutic Lifestyle Interventions for Diabetes Prevention and Management Xavier Pi–Sunyer, M.D., Christopher Gardner, M.D., Charles Webb, D.O., Elisa Tong, M.D., M.A. and Edwin Fisher, Ph.D. Counsel patients about reducing risk for developing type 2 diabetes. Collaborate with patients to design plans for weight loss and fitness. Educate patients about the benefits of smoking cessation. Implement systems to support patients’ self-management of diabetes.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Type 1 Diabetes: Prevention and Management Dorothy Becker, M.B.B.Ch., Janet Silverstein, M.D., Russell White, M.D., Susan Sullivan–Bolyai, D.N.Sc., C.N.S., R.N. and John Anderson, M.D. Summarize the theories related to the etiology of type 1 diabetes. Educate parents of at-risk children about clinical trials aimed at preventing type 1 diabetes. Select patients and families who are likely to benefit from continuous glucose monitoring. Advise patients with type 1 diabetes about the benefits and necessary precautions of exercise and sports. Implement mentor programs to support parents of children with recently diagnosed type 1 diabetes.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Current Topics: Winter 2012 John Buse, M.D., Ph.D., Franklin Zieve, M.D., Robert Lustig, M.D. and John Anderson, M.D. with Brad Munson Counsel patients about potential adverse effects associated with major classes of antidiabetes agents. Summarize the literature about the association between antidiabetes agents and cancer. Discuss the implications of the findings from the Atherothrombosis Intervention in Metabolic Syndrome with Low HDL Cholesterol/High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH) trial. Educate patients about sugar intake and its effect on metabolism and risk for diabetes. Individualize medical management of diabetes, taking age and risk for hypoglycemia into account.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Type 2 Diabetes and Acute Coronary Syndrome Zachary Bloomgarden, M.D., Ronald Krauss, M.D., Wendy Post, M.D., M.S., Alessandro Doria, M.D., Ph.D. and Karin Bornfeldt, Ph.D. Individualize management, addressing all modifiable risk factors for cardiovascular disease (CVD). Assess and manage atherogenic dyslipidemia. Identify appropriate candidates for coronary artery calcium screening and/or exercise stress testing. Argue for or against a role for genetic studies in assessing and reducing risk for CVD. Discuss the applicability of mouse models to the study of diabetes and atherosclerosis in humans.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Debate: Autologous Stem Cell Transplant as Standa Predimen K. (P.K.) Shah, M.D., Darren McGuire, M.D., Peter Grant, M.D., M.B.Ch.B. and David J. Schneider, M.D. Explain why individuals with type 2 diabetes are at elevated risk for acute coronary syndrome (ACS) and consider the clinical implications. Reduce risk for ACS in diabetic patients through appropriate therapeutic interventions. Summarize the evidence in support of permissive hyperglycemia in patients with ACS. Identify appropriate candidates for aggressive antiplatelet therapy.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Additional Continuing Education Options Available...
If you have taken the current course listed here or if you need additional Diabetes credits, please call 800-446-5599 and ask about new courses in stock that are not listed on the website or visit: Medical Courses Coming Soon.
You may also be interested in one of ASI's NEW medical specialties:
If you have taken the current Clinical Pharmacology course listed above or if you are seeking additional continuing education credits, please visit: Medical Courses Coming Soon, for an abbreviated outline of additional medical courses available.
ASI Now Offers 9 NEW Specialties! Click the links below for the current course outline and full information!
What our clients are saying about American Seminar Institute's continuing medical education seminars...
"I was very impressed, as always, with my diabetes seminar. This is a perfect way for me to earn continuing education credits with the fexibility of program, location and schedule!" Jaquie,MD,Tampa, Florida
"..being able to schedule my continuing education around the demands of my family and in such a beautiful location was perfect. I'll tell my friends about you!" Sherry L.,PA,Chicago,
"I find ASI's program to be the best way to earn my continuing medical education. I greatly appreciate, as does my family, the flexibility and ease of your system! Thank you again!" Micalla, NP, Mancado, 2012
Back to Top of ASI's Diabetes CME Review Page
